Recent studies show that the characterization of CTCs and their subpopulations, that is, disseminated tumor cells (DTC), metastasis‐initiating cells and even dual‐positive cells (CD45+/EpCAM+) helps to understand the metastatic behavior of tumors and to deduce prognostic predictions and diagnostic statements [3, 4]. This evidence concerns the gene EPCAM and neoplasm.